S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.42
+1.74
+10.43%
VOR · Vor Biopharma Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$18.93
-0.09
(-0.47%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$18.93
$18.84
$19.69
52-WEEK RANGE
$18.93
$6.50
$30.40
What's happening
- VOR is down 0.47% today, trading at $18.93. — Live quote
- Volume today (43,415) is well below its 3-month average of 1,170,760. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-1.16 actual vs. $-0.71 estimated (-63.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 6
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
VOR
+45.49%
vs S&P 500
+32.71%
1-YEAR RETURN
VOR
-35.34%
vs S&P 500
-49.90%
6-MONTH RETURN
VOR
+27.12%
3-MONTH RETURN
VOR
-5.09%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.16
Est. $-0.71
MISS -63.1%
2026-04-26 (Q1 2026)
$-5.11
Est. $-0.79
MISS -548.3%
2026-01-26 (Q4 2025)
$25.84
Est. $-1.69
BEAT +1625.3%
2025-10-26 (Q3 2025)
$-3.33
Est. $-3.28
MISS -1.4%
Valuation Measures & Ratios
Enterprise Value4$1.01B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)—
Price / Book71.36
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-142.13%
Return on Assets (ROA9)154.23%
Avg Volume (3M)1,170,760
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $996.8M | $766.2M | $324.5M | $201.7M | $89.9M |
| P/E | -0.37 | -0.29 | -0.13 | -0.12 | -0.76 |
| Price/Book | -4.98 | -5.09 | -0.15 | -0.13 | 1.36 |
| ROE | 1333.06% | 1754.02% | 109.93% | 110.35% | -179.64% |
| ROA | -554.77% | -520.66% | -1388.13% | -809.05% | -108.58% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short7,814,764
Change from Prior Settlement-1.14%
% of Float—
Days to Cover (Short Ratio)4.34
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -35.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on VOR
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$47.9M | -$35.2M | -$28.1M | -$274.3M | -$33.3M | -$28.5M | -$29.0M | -$32.3M |
| Net income | -$62.8M | -$219.6M | -$812.7M | -$1.57B | -$32.5M | -$27.6M | -$27.8M | -$30.8M |
| EPS (diluted) | $-1.16 | $-5.11 | $-121.63 | $-251.24 | $-5.21 | $-8.05 | $-0.41 | $-0.45 |
| EPS (basic) | $-1.16 | $-5.11 | $-121.63 | $-251.24 | $-5.21 | $-8.05 | $-0.41 | $-0.45 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $481.1M | $506.7M | $464.1M | $176.2M | $205.4M | $109.3M | $142.9M | $116.0M |
| Total liabilities | $681.2M | $657.2M | $628.4M | $2.40B | $1.71B | $43.2M | $46.2M | $43.0M |
| Stockholders' equity | -$200.2M | -$150.4M | -$164.3M | -$2.23B | -$1.51B | $66.1M | $96.7M | $73.0M |
| Total current assets | $475.1M | $500.8M | $458.1M | $172.5M | $204.9M | $64.8M | $96.5M | $67.3M |
| Total current liabilities | $24.8M | $16.1M | $25.2M | $18.8M | $58.8M | $16.7M | $18.6M | $14.3M |
| Cash & equivalents | $107.9M | $169.9M | $396.5M | $160.5M | $190.6M | $50.0M | $81.9M | $52.8M |
| Marketable securities (current) | $358.3M | $321.7M | $58.7M | $10.0M | $10.0M | $10.0M | $10.0M | $10.0M |
| Other current assets | $3.1M | $2.9M | $1.7M | $1.3M | $449.0K | $297.0K | $380.0K | $285.0K |
| Property, plant & equipment | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6.0M | $6.6M | $7.5M |
| Other non-current assets | $2.4M | $2.4M | $2.4M | $269.0K | $420.0K | $2.4M | $2.4M | $2.5M |
| Accounts payable | $4.0M | $1.0M | $5.1M | $885.0K | $669.0K | $3.7M | $1.5M | $1.3M |
| Accrued liabilities | $20.5M | $14.7M | $19.8M | $17.7M | $58.1M | $8.7M | $12.9M | $8.9M |
| Other current liabilities | — | — | — | — | — | $44.0K | $0 | $13.0K |
| Common stock & paid-in capital | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K |
| Retained earnings | -$1.44B | -$1.37B | -$1.15B | -$2.88B | -$2.06B | -$489.5M | -$457.0M | -$426.3M |
| Accumulated other comprehensive income (loss) | -$922.0K | -$706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$25.4M | -$38.2M | -$22.8M | -$53.7M | -$35.2M | -$31.1M | -$24.1M | -$23.3M |
| Investing cash flow | -$36.5M | -$263.2M | -$49.0M | -$244.0K | $646.0K | -$230.0K | -$72.0K | -$34.0K |
| Financing cash flow | -$106.0K | $74.9M | $307.8M | $21.5M | $175.1M | -$606.0K | $53.3M | $41.0K |
| Free cash flow | -$25.5M | -$38.3M | -$23.1M | -$53.9M | -$35.3M | -$31.3M | -$24.1M | -$23.3M |
| Capital expenditures | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K |
| Share-based compensation | $9.4M | $8.9M | $7.1M | $8.0M | $1.8M | $1.9M | $1.7M | $2.3M |
| Purchases of investments | $79.0M | $276.5M | $53.7M | $0 | $0 | $0 | $0 | $0 |
| Tax withholding on stock comp | $2.0K | $2.0K | $148.0K | $19.0K | $32.0K | $55.0K | $30.0K | $70.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$371.6M | -$121.2M | -$126.0M | -$93.4M | -$69.0M |
| Net income | -$696.0M | -$116.9M | -$117.9M | -$92.1M | -$68.9M |
| EPS (diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
| EPS (basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $464.1M | $142.9M | $198.1M | $299.4M | $242.6M |
| Total liabilities | $628.4M | $46.2M | $47.4M | $48.8M | $26.3M |
| Stockholders' equity | -$164.3M | $96.7M | $150.7M | $250.6M | $216.3M |
| Total current assets | $458.1M | $96.5M | $140.8M | $236.9M | $214.4M |
| Total current liabilities | $25.2M | $18.6M | $15.6M | $13.1M | $10.2M |
| Cash & equivalents | $396.5M | $81.9M | $31.4M | $57.7M | $119.8M |
| Marketable securities (current) | $58.7M | $10.0M | $105.8M | $172.5M | $87.7M |
| Other current assets | $1.7M | $380.0K | $475.0K | $2.3M | $2.1M |
| Property, plant & equipment | $533.0K | $6.6M | $10.1M | $12.6M | $6.9M |
| Other non-current assets | $2.4M | $2.4M | $4.8M | $2.9M | $3.3M |
| Accounts payable | $5.1M | $1.5M | $815.0K | $1.8M | $1.5M |
| Accrued liabilities | $19.8M | $12.9M | $10.9M | $7.9M | $6.3M |
| Other current liabilities | — | $0 | $50.0K | $186.0K | $434.0K |
| Common stock & paid-in capital | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K |
| Retained earnings | -$1.15B | -$457.0M | -$340.1M | -$222.2M | -$130.1M |
| Accumulated other comprehensive income (loss) | $41.0K | $22.0K | -$77.0K | -$770.0K | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$142.7M | -$99.7M | -$100.3M | -$85.1M | -$69.1M |
| Investing cash flow | -$48.8M | $96.9M | $71.0M | -$94.1M | -$91.7M |
| Financing cash flow | $503.8M | $53.4M | $2.9M | $117.1M | $232.9M |
| Free cash flow | -$143.7M | -$99.9M | -$101.4M | -$93.6M | -$73.0M |
| Capital expenditures | $941.0K | $229.0K | $1.1M | $8.5M | $3.9M |
| Share-based compensation | $18.9M | $9.8M | $13.4M | $10.7M | $4.3M |
| Purchases of investments | $53.7M | $9.9M | $74.9M | $123.2M | $87.8M |
| Tax withholding on stock comp | $254.0K | $333.0K | $1.2M | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding VOR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-10-23 to 2026-10-02
Recent transactions
- Insiders have net sold 165,363 shares over the last 182 days, across 0 purchases and 2 sales.
- Most recent: RA CAPITAL MANAGEMENT, L.P. (Reporting person) — Option exercise of 500 shares on 2026-10-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)165,363 sh(2 txns)
Net Shares-165,363
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Reporting person | Option exercise | 2026-10-02 | 500 |
| Mahatme Sandesh | CFO | Disposition to issuer | 2025-12-05 | 694,137 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-02 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Option exercise | 500 | $12.80 |
| 2026-08-24 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Option exercise | 1,500 | $3.74 |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | In-the-money option exercise | 2,100,000 | $0.00 |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 213 | $19.75 |
| 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 165,150 | $15.77 |
| 2026-04-20 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 171,963 | $15.77 |
| 2026-04-17 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 458,411 | $16.28 |
| 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 53,644 | $16.01 |
| 2026-04-14 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 153,735 | $15.97 |
| 2026-04-13 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 530,610 | $16.15 |
| 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 828 | $15.75 |
| 2026-04-09 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 135,201 | $16.59 |
| 2026-04-08 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 353,242 | $16.32 |
| 2026-04-08 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 130,862 | $16.91 |
| 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 537,754 | $16.51 |
| 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 44,728 | $17.31 |
| 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 6,775 | $18.50 |
| 2026-04-02 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 258,475 | $18.23 |
| 2026-04-02 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 1,525 | $19.06 |
| 2025-12-18 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Grant / award | 4,625,346 | $10.81 |
| 2025-12-05 | Mahatme Sandesh | CFO | Disposition to issuer | 694,137 | $0.00 |
| 2025-10-30 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 24,579 | $25.12 |
| 2025-10-29 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 251,518 | $25.22 |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 87,828 | $27.10 |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 36,483 | $28.18 |
| 2025-10-27 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 90,941 | $28.12 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 53,345 | $28.01 |
| 2025-10-23 | RA CAPITAL MANAGEMENT, L.P. | Reporting person | Open market sale | 76,880 | $28.01 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:16 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-21 | 4 | 2026-07-16 | View on SEC.gov → |
| 2026-07-09 | 4 | 2026-07-07 | View on SEC.gov → |
| 2026-07-07 | 8-K | 2026-07-06 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
Recent news
Headlines about VOR (Vor Biopharma Inc.). Links open the publisher — we don’t host full articles.
-
VOR Initiates Coverage On Vor Biopharma -- Rating "Outperform" b
GuruFocus · 2026-10-21 -
William Blair Starts Vor Biopharma, Inc. (VOR) at Outperform
StreetInsider · 2026-10-21 -
William Blair Initiates Coverage On Vor Biopharma with Outperform Rating
Benzinga · 2026-10-21 -
VOR May 2027 12.500 call (VOR270521C00012500) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
Discipline and Rules-Based Execution in VOR Response
Stock Traders Daily · 2026-10-19 -
VOR May 2027 30.000 put (VOR270521P00030000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-18 -
VOR270219C00015000 Interactive Stock Chart | VOR Feb 2027 15.000 call Stock
Yahoo Finance · 2026-10-18 -
VOR Feb 2027 22.500 call (VOR270219C00022500) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-18
No headlines in this category right now — try “All”.